PER 1.27% 7.8¢ percheron therapeutics limited

ann in, page-7

  1. 570 Posts.
    lightbulb Created with Sketch. 58
    " To date no patients dosed with ATL1103 have withdrawn from the study nor have any serious adverse events been reported"


 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.